Dezima Pharma B.V.
Records under this name other than the patents Dezima Pharma B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 8 of 8 · Back to Dezima Pharma B.V.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,872,126 | Tetrahydroquinoline derivatives and a process for preparing the same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,084,611 | Process for preparing tetrahydroquinoline derivatives Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,653,692 | Cholesteryl Ester Transfer Protein (CETP) Inhibitor and Pharmaceutical Compositions Comprising Said Inhibitor for Use in the Treatment or Prevention of Cardiovascular Diseases Formerly held In force · High confidence | In force | High confidence | |
| US 11,013,742 | Cholesteryl Ester Transfer Protein (CETP) Inhibitor and Pharmaceutical Compositions Comprising Said Inhibitor for Use in the Treatment or Prevention of Cardiovascular Diseases Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,186,315 | Cholesteryl Ester Transfer Protein (CETP) Inhibitor and Pharmaceutical Compositions Comprising Said Inhibitor for Use in the Treatment or Prevention of Cardiovascular Diseases Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,112,904 | Process for Preparing Synthetic Intermediates for Preparing Tetrahydroquinoline Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 10,300,059 | Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and HMG CoA reductase inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,158,640 | Tetrahydroquinoline derivatives and a process for preparing the same Formerly held Term ended Term ended Apr 1, 2025 · From the USPTO record | Term ended | Term ended Apr 1, 2025 | From the USPTO record |